An observational study in Cataract, sponsored by Rush Eye Associates. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-28.
Sponsored by Rush Eye Associates · Observational
To analyze the economics of office-based (OBS) versus ambulatory surgery center (ASC)-based cataract surgery.
This study was conducted as a randomized, controlled clinical trial at a single private practice institution. Patients presenting for routine cataract surgery scheduling were randomized prospectively to undergo the procedure in either the OBS or ASC-based setting. The primary outcome was total average cost for performing OBS versus ASC-based cataract surgery. The secondary outcome was total average facility reimbursement for OBS versus ASC-based cataract surgery.
1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.
This study's enrollment of 76 is close to the median of 81 across 484 observational studies indexed under Cataract.
Browse Cataract studies →Rush Eye Associates is the lead sponsor of 8 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Visually significant cataract
Exclusion Criteria:
Procedure: Office based surgery
Study subjects underwent office-based cataract surgery.
Cost
Average cost for office based surgery
Time frame: 1 day
Average cost for office-based surgery
US dollars
Time frame: Single surgical event
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rush Eye Associates